Validation of podocalyxin-like protein as a biomarker of poor prognosis in colorectal cancer
about
Podocalyxin enhances breast tumor growth and metastasis and is a target for monoclonal antibody therapyA comparative study of two PODXL antibodies in 840 colorectal cancer patients.Incident urothelial cancer in the Malmö Diet and Cancer Study: cohort characteristics and further validation of ezrin as a prognostic biomarker.Podocalyxin is a marker of poor prognosis in colorectal cancerSATB1 is an independent prognostic factor in radically resected upper gastrointestinal tract adenocarcinomaSystematic antibody generation and validation via tissue microarray technology leading to identification of a novel protein prognostic panel in breast cancer.Identification of miR-145 targets through an integrated omics analysis.Early diagnostic value of Bcl-3 localization in colorectal cancer.Prognostic and predictive significance of podocalyxin-like protein expression in pancreatic and periampullary adenocarcinoma.Podocalyxin Is a Marker of Poor Prognosis in Pancreatic Ductal Adenocarcinoma.Podocalyxin as a Prognostic Marker in Gastric CancerExpression of podocalyxin-like protein is an independent prognostic biomarker in resected esophageal and gastric adenocarcinoma.Prognostic role of podocalyxin-like protein expression in various cancers: A systematic review and meta-analysis.The Universal 3D3 Antibody of Human PODXL Is Pluripotent Cytotoxic, and Identifies a Residual Population After Extended Differentiation of Pluripotent Stem CellsSignificant association and synergistic adverse prognostic effect of podocalyxin-like protein and epidermal growth factor receptor expression in colorectal cancerMembranous expression of podocalyxin-like protein is an independent factor of poor prognosis in urothelial bladder cancer.Podocalyxin-like protein expression in primary colorectal cancer and synchronous lymph node metastases.Podocalyxin-like and RNA-binding motif protein 3 are prognostic biomarkers in urothelial bladder cancer: a validatory study.Somatic gene copy number alterations in colorectal cancer: new quest for cancer drivers and biomarkers.Identification of LEA, a podocalyxin-like glycoprotein, as a predictor for the progression of colorectal cancerIdentification of a characteristic copy number alteration profile by high-resolution single nucleotide polymorphism arrays associated with metastatic sporadic colorectal cancer
P2860
Q21146638-F0704F6C-D542-4199-8A22-54A779B9161EQ33938468-DD2F22F1-B7F9-4922-9576-F70B32298F1AQ34333522-F6DA3D81-E439-4A97-9037-0A1B8A62470FQ34485223-A0D2363B-33C9-4870-B15A-9AA1FF7EB6B5Q34577656-D634BDC9-E556-4B58-B8F5-86378E6DB7BDQ34644894-10882B66-70CA-43A2-9185-C3D457627F69Q35155627-8DB8947B-AD50-4345-827E-46745DCA5DB4Q35615515-0A90A89C-79CB-40CD-AA15-E69D8138A5B8Q35647464-95A170E6-4851-4D0B-91BE-850A613131A6Q35656610-EE4C1C21-7C3E-4EFC-9418-05C326ADDE3CQ35870705-B335A5C5-A2FC-482F-A478-79045EC075D6Q36091414-B7737BFE-5599-4FBC-8D38-346363AF8DD7Q36236781-CF8AA7DA-5CF3-4DB6-99AE-764AD1097A10Q36756141-1A379E5A-B314-4D3B-95CF-52F6FEA82D5BQ36886612-24BE15F9-F167-4DDB-9F7C-6A247236EBBBQ36924797-DD1E58F1-E10B-4FA3-8FD7-11829E78A028Q37114865-7834E9F1-3A31-4CF4-B81C-B01568934835Q37697790-6086F53E-CFB0-4E63-923C-B8786D436EABQ38563527-10D8261D-4075-4206-85B5-EF6B1DD38D7EQ57112164-E5AE99DF-A150-4917-8467-C2B413CA496CQ58051474-ED67A482-4AB0-4214-9B86-AF1CB49CD39A
P2860
Validation of podocalyxin-like protein as a biomarker of poor prognosis in colorectal cancer
description
2012 nî lūn-bûn
@nan
2012 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Validation of podocalyxin-like ...... prognosis in colorectal cancer
@ast
Validation of podocalyxin-like ...... prognosis in colorectal cancer
@en
Validation of podocalyxin-like ...... prognosis in colorectal cancer
@nl
type
label
Validation of podocalyxin-like ...... prognosis in colorectal cancer
@ast
Validation of podocalyxin-like ...... prognosis in colorectal cancer
@en
Validation of podocalyxin-like ...... prognosis in colorectal cancer
@nl
prefLabel
Validation of podocalyxin-like ...... prognosis in colorectal cancer
@ast
Validation of podocalyxin-like ...... prognosis in colorectal cancer
@en
Validation of podocalyxin-like ...... prognosis in colorectal cancer
@nl
P2093
P2860
P3181
P356
P1433
P1476
Validation of podocalyxin-like ...... prognosis in colorectal cancer
@en
P2093
Alexander Gaber
Anna Larsson
Björn Nodin
Göran Jönsson
Helgi Birgisson
Marie Fridberg
Per Levéen
P2860
P2888
P3181
P356
10.1186/1471-2407-12-282
P407
P577
2012-07-08T00:00:00Z
P5875
P6179
1004982970